Skip to main content
main-content

01.12.2017 | Research article | Ausgabe 1/2017 Open Access

BMC Neurology 1/2017

A systematic review and narrative synthesis of group self-management interventions for adults with epilepsy

Zeitschrift:
BMC Neurology > Ausgabe 1/2017
Autoren:
Amelia Smith, Alison McKinlay, Gabriella Wojewodka, Leone Ridsdale
Abbreviations
DESMOND
Diabetes education and self-management for ongoing and newly diagnosed
ESES
Epilepsy self-efficacy scale
ESMS
Epilepsy self-management scale
MOSES
Modular service package epilepsy
PHQ-9
Patient health questionnaire 9
PWE
People with epilepsy
QoL
Quality of life
QOLIE
Quality of life in epilepsy
SWLS
Satisfaction with life scale
TAU
Treatment as usual
WHOQOL-BREF
World health organisation quality of life abbreviated version

Background

Epilepsy is a long-term condition characterised by recurrent seizures, with a prevalence of around 1% in the general population [1, 2]. Common consequences of living with epilepsy include driving limitations, detrimental effects on education, unemployment, and diminished psychological wellbeing [3]. Stigma, frequency of seizures, and healthcare experiences also affect quality of life (QoL) in people with epilepsy (PWE) [4].
Epilepsy has significant financial and social costs. Direct costs are associated with a high rate of emergency admission that occurs with poorly-controlled epilepsy [5]. Emergency service use makes up the majority of admissions for epilepsy. Among all long-term conditions, epilepsy is the sixth most common cause of emergency admission in the United Kingdom [6, 7]. Reducing unnecessary emergency admissions is a key factor in helping to relieve financial pressure on healthcare services. Another major social issue is the indirect cost of epilepsy due to lost employment [8]. The health and social costs could be reduced and QoL improved via better outpatient management. However, around 40% of those diagnosed have poorly-controlled epilepsy and continue to have two or more seizures per year, [3] despite using antiepileptic drugs (AEDs). These figures highlight missed opportunities for epilepsy self-management.
Management of long-term conditions requires self-efficacy and empowerment, enabling patients to live as independently as possible and reducing the need to go to hospital [9]. For other long-term conditions, strategies for enabling such behaviour have been attempted within self-management education courses. A diabetes group intervention used in the United Kingdom, called DESMOND, is a cost-effective intervention, shown to improve biopsychosocial outcomes [1012]. The programme is structured and can be run over one to two days for six hours in total [12]. Content is based on social learning theory [13] and is integrated into standard outpatient care for diabetes.
Early research evidence from North America [14] and Germany [15] suggested that group self-management courses had the potential to have a positive effect on health outcomes in PWE. The interest in group self-management for PWE has grown; however, the evidence base for developing self-management groups as standard outpatient care for PWE is still small. The objectives of this review were to evaluate recent research and summarise results of group self-management interventions for PWE. This was undertaken in the context that our group was conducting a trial of group self-management education intervention in the UK [16].

Methods

Study eligibility criteria

Population

PWE, adults aged 16 or over, without learning disabilities (due to the markedly different approaches required for educational programs in these populations [17]).

Intervention

Group self-management interventions were the focus of this review, irrespective of the study objectives (i.e., education, behavioural therapy, or a combination were included). We were interested in the psychological and social elements of face-to-face, group self-management courses. Studies using telemedicine were therefore excluded, as they are not provided face-to-face in groups.

Comparison

Treatment as usual or waitlist control.

Outcomes of interest

There was particular interest in QoL as this is the outcome favoured by the National Institute for Health and Care Excellence (NICE) [18, 19]. However, as there is no fixed consensus on the best measure for evaluating group interventions, we also included studies assessing other outcomes such as seizure frequency, psychological state, self-efficacy, and knowledge of epilepsy.

Exclusion criteria

Studies reporting trial protocol without results, one-to-one interventions, web- or telephone-based interventions, and samples including people with learning disabilities, children or non-epileptic seizures.
We searched for papers published from 1990 to 2015. A randomised controlled trial is considered the “gold standard” research design for evaluating the efficacy of an intervention; [20] however, we extended search criteria to include other forms of clinical trial (i.e., controlled outcomes design).

Search strategy

We conducted electronic searches of the databases Medline and PsycINFO using the following keywords: epilepsy, seizures, self-care/self-efficacy, patient education/education programme, self-management, group intervention/complex intervention. A manual search of reference lists was performed to identify further relevant studies. For specific strategies for database searches refer to Appendix 1.

Quality appraisal

All studies were assessed for quality using the CONSORT guidelines for reporting clinical trials [21]. Studies were assigned a number between 0 (description absent) and 2 (satisfactory description) according to how fully they described the four sections: trial design (methodology), participants (study sample and characteristics), interventions and study outcomes. Appraisal was carried out by two independent assessors and studies were discussed as a group to resolve any disagreements. The Cochrane approach was used to categorise the studies into ‘high’, ‘low’ or ‘unclear’ risk of bias with regard to random sequence generation and allocation concealment [22]. As it is not possible to double-blind a group self-management intervention, this was not included in the quality assessment.

Results

Study selection

The first author conducted the initial literature search, which was repeated by the second author. The initial Medline search resulted in 42 papers being identified (Fig. 1). After examining the titles and abstracts, nine were unrelated and were excluded. Five studies on non-epileptic seizures (psychogenic seizures and febrile convulsions) were excluded also [2327]. Five more were excluded as their participant population consisted of children (under 16) or patients with learning disabilities. Of the remaining papers, six were identified as involving a telephone or web-based intervention and were also excluded. Finally, some studies were excluded because no group intervention was administered. The papers described either individual care programmes or trial protocols with no results.
PsycINFO returned 32 results; three new papers were identified, but none were eligible for inclusion (two protocols, one telemedicine). Two studies were included from the manual literature search, resulting in 11 studies in total.

Search results

Of the 11 studies included with this review (Table 1), nine were described by their authors as randomised controlled trials [15, 2830, 31, 3235] and the remaining two as controlled outcome designs [36, 37]. The first study included a matching strategy for allocating participants to control or treatment group [37]. The second study used random assignment but did not provide more specific protocol information [36]. After synthesising review results, we established that due to outcome heterogeneity a meta-analysis would not be possible.
Table 1
Summary of included papers
Author
Participants
Intervention (int.)
Facilitator
Control
Outcome measures
Main findings
Aliasgharpour et al. [33]
60 PWE randomised
Aged 18–70
Diagnosed for ≥1 yr.
Experienced seizures in the past year
1 month educational int.
Four 2 hr sessions
Face-to-face lectures with case histories, demonstrations and information leaflets to take away
Group size: 4–6. Discrete intervention
Master’s student in nursing
TAU
ESMS
Pre-intervention and 1 month follow-up
Self-management score significantly improved in int. vs control
Au et al. [37]
17 adults with
epilepsy (age range not specified)
≥ 2 seizures a month
8 week psychological CBT int.
Eight 2 hr structured sessions
Group size: 8
Discrete intervention
2 clinical psychologists trained in seizure management
TAU
QOLIE-31, ESES, seizure frequency
3 months pre-int. and
3 month follow-up
Significant improvement in QoL and self-efficacy scores in intervention group vs control
No difference in seizure frequency
Fraser et al. [35]
83 PWE randomised
Age ≥ 18
Diagnosed for ≥6 months
8 week psychoeducational int.
Eight 75 min sessions
Presentations, facilitated discussion and workbook
Group size: 6–8. Discrete int.
Rehabilitation psychologist and trained peer mentor
WC
QOLIE-31, ESMS, ESES,
PHQ-9, GAD-7
Pre-int., 8 week and 6 month follow-up
QoL, self-efficacy and PHQ-9 scores improved at 8 weeks in int. group but not significant at 6 months.
Self-management significantly improved at 6 months
Helde et al. [29]
111 PWE aged 16–70
Diagnosed for ≥1 yr.
≥ 1 seizure in the past yr
1 day educational int.
Information and discussion about epilepsy and psychosocial aspects
Group size: 5–11
Additional input: telephone follow-up and 1–1 counselling from nurse
MDT (the study nurse, neurologist, social worker, and neurophysiologist)
TAU
QOLIE-89 and general patient satisfaction score
Pre-randomisation and at
2 year follow-up
Significant improvement in QoL score in int. group at follow-up but no sig difference between int. and control
Significant increase in satisfaction in int. vs control
Ibinda et al. [34]
738 PWE randomised
581 data analysed
≥ 1 seizure in the past yr
1 day educational int.
Information about epilepsy provided using role play, discussion, narratives and brochure on the topics was given
Group size: up to 20. Discrete int.
Non-specific ‘researchers
and field staff’
WC
AED adherence, seizure frequency, KEBAS
(Kilifi epilepsy beliefs and
Attitudes scores)
Pre-int. and after 1 year follow-up
Significantly improved KEBAS scores in int. vs control at follow-up.
No difference in adherence or seizure frequency between the groups (both improved significantly)
Losada-Comacho et al. [28]
182 women with
epilepsy randomised
Age ≥ 18
Diagnosed ≥1 yr.
≥ 1 seizure in the past 3 yrs
Educational int. part of pharmaceutical care programme
Monthly lectures and information brochures
Group size: not specified
Additional input: 1–1 medication reviews. Given adherence aids and seizure journals
Pharmacist trained in epilepsy management
TAU and seizure
Information brochure
QOLIE-31, seizure frequency, adverse events,CES-D
(depression), Haynes-Sackett and Morinski-Green tests (medication adherence)
Pre-int. and after 6 month follow-up
Highly significant improvement in QoL score between int. and control groups at follow-up.
Other outcomes not reported in the paper
Lundgren et al. [30]
27 PWE randomised Aged 21–55 ≥ 4 seizures in the past 3 months
Psychological ACT int.
Two 3 hr sessions
Group size: 6–8
Additional input: Two individual 90 min sessions, individualised seizure control techniques
2 clinical psychologists
Supportive therapy
WHOQOL-BREF, SWLS, seizure index
Pre-int, post-int, and at 6 month and 1 year follow-up
Significant improvement in seizure index at all time points post-int. in int. group vs control. Significant improvement in QoL scores in int. group after 1 year
May and Pfafflin, [15]
383 PWE randomised
Age ≥ 16
Any duration or severity of epilepsy
2 day educational int.
Interactive course with 9 modules aiming to improve knowledge of epilepsy and psychosocial factors
Group size: not specified. Discrete int.
Non-specific ‘trainers’
TAU
SF-36, Depression Scale D-S′, Rosenberg self-esteem, stigma, restrictions due to epilepsy, epilepsy-related fears and mobility and leisure scales, specifically developed epilepsy knowledge and coping with epilepsy scales. Seizure frequency Pre-int. and 6 month follow-up
Significant improvement in knowledge and coping scales (specifically developed) in int. group.
Significant improvement in seizure frequency in int. group.
No impact on QoL (SF-36 score)
McLaughlin and McFarland, [32]
37 older adults with epilepsy
Age ≥ 60
6 week psychological CBT int.
Six 2 h sessions
Spector et al. protocol, modified for older adults with less content and diaries to aid memory
Group size: 6–7. Discrete int.
Psychologist with epilepsy expertise
Relaxation training
GDS, CIDI-auto, WPSI, seizure frequency
Pre-int, post-int. and after 3 month follow-up
Significant improvement in seizure frequency in int. group vs control.
No significant difference between groups in other measures but depression and psychosocial functioning improved in both.
Olley et al. [36]
30 PWE allocated to groups
Aged 21–65
2 day psychoeducational int.
Educational sessions and group discussion on epilepsy, stigma & management
Group size: not specified. Discrete int.
Non-specific ‘researcher/therapist’
WC
CCEI, BDI (psychological symptoms), knowledge about epilepsy
Pre-int, post-int and after 2 month follow-up
Significant improvement in int. group vs control in psychological scales and increased knowledge about epilepsy at follow-up
Pramuka et al. [31]
55 PWE randomised
Age ≥ 18
6 week psychoeducational int.
Six 2 hr sessions
Presentations, activities and discussion on medical and self-management topics
Written information provided
Group size: 4–12. Discrete int.
2 psychologists and 1 research associate
Guest lecture by nurse specialist
TAU
QOLIE-89, ESES, WPSI (psycho-social factors), locus of control scale, MCMI-III (depression)
Pre-int. and 1 month follow-up
Trends in improved direction in all measures, but only one QoL subscale showed significant improvement in int. group vs control at follow-up.
PWE people with epilepsy; yr. year; int intervention; hr. hour; TAU treatment as usual; ESMS Epilepsy Self-Management Scale; CBT Cognitive Behaviour Therapy; QOLIE Quality of Life in Epilepsy; ESES Epilepsy Self-Efficacy Scale; QoL Quality of Life; WCwaitlist control; PHQ-9 Patient Health Questionnaire-9; GAD-7 Generalised Anxiety Disorder-7; MDT multidisciplinary team; ACT Acceptance and Commitment Therapy; WHOQOL-BREF World Health Organisation quality of life – abbreviated version; SWLS: Satisfaction with Life Scale; SF-36 36-item short form survey; GDS Geriatric Depression Scale; CIDI-auto Composite International Diagnostic Interview; WPSI Washington Psychosocial Seizure Inventory; CCEI Crown-Crisp Experiential Index; BDI Beck Depression Inventory; MCMI-III: Millon Clinical Multiaxial Inventory -III
All studies focused on the effects of a group intervention in PWE, with one exclusively recruiting women [28] and another looking at older adults [32]. Most studies targeted poorly-controlled epilepsy; however, the definition of ‘poorly-controlled’ varied and four studies did not specify a minimum seizure frequency.
We assessed 11 studies for quality and risk of bias (Table 2). For most studies, the participants and outcome measures were well described. Trial design was the least well described throughout the 11 studies followed by the intervention description. Eight of the 11 studies had low risk of bias for the generation of the sequence allocating participants to treatment groups. In most study designs for self-management courses, the participants and facilitators will be un-blinded. Other research staff, such as those assessing participants and analysing data should have remained blinded to minimise bias. The concealment of group allocation was not described in the majority of studies.
Table 2
Quality ratings and risk of bias
Study
Quality appraisal
Risk of bias appraisal
Trial design
Participants
Intervention
Outcomes
Total (max 8)
Sequence generation
Risk of bias
Allocation concealment
Risk of bias
Aliasgharpour et al. [33]
1
1.75
2
2
6.75
Random number table
Low
Not described
Unclear
Au et al. [37]
0.75
2
2
2
6.75
Matched design
Unclear
Not described
Unclear
Fraser et al. [35]
1.75
2
1.75
2
7.5
Random number generator
Low
Not described
Unclear
Helde et al. [29]
1.25
2
2
2
7.25
Computer-generated block randomisation
Low
Research assistant blinded
Low
Ibinda et al. [34]
1.25
1.25
0.5
1.5
4.5
Computer-generated randomisation
Low
Not described
Unclear
Losada-Camacho et al. [28]
2
2
1.75
2
7.75
Drawing of ballot papers
Low
Sequentially numbered, opaque, sealed envelopes
Low
Lundgren et al. [30]
1
2
2
2
7
Computer-generated randomisation
Low
Not described
Unclear
May and Pfafflin. [15]
1.25
2
0.75
1.5
5.5
Not described
Unclear
Not described
Unclear
McLaughlin and McFarland [32]
1
1.75
2
2
6.75
Computer-generated randomisation
Low
Not described
Unclear
Olley et al. [36]
1.5
2
1.25
1.75
6.5
Alternate clinic visit
High
Not described
Unclear
Pramuka et al. [31]
1.5
2
2
2
7.5
Random number table
Low
Consecutively numbered, sealed envelopes
Low

Facilitators and treatment groups

Interventions were categorised as educational, [15, 28, 29, 33, 34] psychological (e.g. behavioural therapy) [30, 32, 37] and psychoeducational programmes (i.e. both) [31, 35]. Psychological and psychoeducational interventions were delivered by psychologists, whereas educational sessions were delivered by a range of practitioners. In two studies, [34, 36] instructors’ qualifications were not clearly specified (e.g. ‘researcher’ or ‘staff’). In one study, [15] facilitators were specified in a previous publication to be physicians, nurses, psychologists, social workers and occupational therapists.
The treatment of the control group varied across the studies. In six of the studies, [15, 28, 29, 31, 37, 33] controls received treatment as usual (TAU). Additional input was given to the controls alongside TAU in one study [33] in the form of two short telephone calls. In two, [30, 32] a control for attention was offered, for example, supportive therapy, involving equivalent attention from professionals, but without any active teaching or advice. Three studies [3436] used a waitlist control design and offered intervention materials after follow-up.

Outcomes

The most frequently assessed outcome measure was QoL, used in seven studies included within this review [15, 2830, 31, 35, 37]. The Quality of Life in Epilepsy questionnaire (QOLIE-31/QOLIE-89) [38, 39] was commonly chosen to assess it [28, 29, 31, 35, 37]. Six studies [15, 28, 30, 32, 34, 37] measured seizure frequency as a marker of control and three assessed self-efficacy, [31, 35, 37] using the Epilepsy Self-Efficacy Scale (ESES) [40]. Two studies [33, 35] used a specific self-management outcome measure called the Epilepsy Self-Management Scale (ESMS) [41]. Different measures were used to assess psychological symptoms, such as the Patient Health Questionnaire (PHQ-9) [42]. Comparison between the studies was complicated, due to the heterogeneity of outcome measures that were used.

Follow-up

The duration of follow-up ranged from one month [33] to two years [29] with a median follow-up period of six months. All studies recorded outcome measures at baseline before the intervention and at the end of follow-up. Four also took further measures immediately post-intervention or halfway through the follow-up period [30, 32, 35, 36].

Overview of findings

Quality of life

Of the seven studies using QoL outcome measures, three showed no significant difference in total QoL scores between the intervention and control groups [15, 29, 31]. Fraser et al. showed a significant improvement in QOLIE-31 scores eight weeks post-intervention, but no statistical significance between means after six months [35].
Two psychological interventions showed an improvement in QoL scores at follow-up. The cognitive behavioural therapy study demonstrated a significant QOLIE-31 score improvement in the intervention group compared with the control at the end of a three month follow-up [37]. Emotional Wellbeing was the only subscale that was significantly increased. In the trial by Lundgren et al [30]. there was a significant improvement in WHOQOL-BREF score (World Health Organisation Quality of Life Assessment abbreviated version) [43] in the acceptance and commitment therapy group, compared to supportive therapy at the final one year follow-up. The Satisfaction with Life Scale (SWLS) [44] score was improved at all three time points after the intervention.
One education-focused study showed an improvement in QoL score. The trial by Losada-Camacho et al. found significant improvement in QOLIE-31 after six months [28]. The intervention package was offered to women only, and focused on pharmaceutical aspects of epilepsy self-management. As one of the co-interventions, participants received advice and monitoring at set intervals from a pharmacist. At six-month follow-up, the total score increased in the intervention group by 12.45 points compared with a 2.61 increase in the controls.

Seizure frequency

Six studies measured seizure frequency. Three found that seizure frequency decreased significantly in the intervention group compared with controls [28, 30, 32]. However, two studies did not find a significant difference in seizure frequency post-intervention. Au et al. described a small improvement in the intervention group but this was not significant, [37] whereas, Ibinda et al. found a decrease in both groups but no difference between them [34]. One study did not report seizure frequency despite collecting this data [28]. The reason for this was unclear; however, it may be due to poor compliance with seizure diaries as only 37.5% of participants returned them.

Self-management and self-efficacy

Two studies using the ESMS showed promising findings after group intervention delivery. Aliasgharpour et al. found a significant difference between the groups post-intervention with an increase in self-management score in the intervention group but none in the control [33]. Likewise, Fraser et al. found a treatment effect favouring the intervention at eight weeks which, although small, remained significant at the six month follow-up [35].
Three studies used the ESES to measure self-efficacy [31, 35, 37]. Fraser et al. found a significant treatment effect in ESES score after eight weeks but this did not persist at six months. Au et al. found a significant improvement in score in the intervention group compared to control. Findings from Pramuka et al. showed a trend towards improvement in the intervention group but this was not significant.

Psychological symptoms

Two of the six studies which used symptom scales indicating psychological comorbidity showed statistically significant improvement [35, 36]. Fraser et al. found a statistical significant change in PHQ-9 [39] score with reductions in depressive symptom severity at eight weeks post-intervention; however, the difference between intervention and control was not statistically significant at six months. Olley et al. found an improvement in psychological state compared with controls but, with only two months follow-up, no long-term benefit was demonstrated [36]. The others found improvements which were not significant [28, 31, 32]. In the study by Losada-Camacho et al. the psychological outcome results were not reported, [28] nor were they published elsewhere.

Discussion

Quality assessment revealed gaps in the methodological reporting of many studies, especially regarding trial design. Risk of bias was assessed and most papers fell into the ‘unclear’ category due to insufficient description of treatment concealment. We paid particular attention to who delivered each intervention and how thoroughly this was described. Information about the role and training of facilitators is needed in order to replicate an intervention and apply it to other healthcare settings.
The usefulness of study findings is somewhat diminished in those that lacked thorough reporting of treatment fidelity. Most interventions were delivered multiple times, sometimes by different facilitators; however, only one study discussed means of ensuring treatment fidelity but the results were not presented [30]. Group interventions may not be delivered consistently and without reporting on measures to prevent deviation, it is uncertain whether interventions were delivered as planned.
All studies reported significant improvement in the intervention group compared with controls in at least one measure. More than half of the studies assessing QoL found some positive effect from the intervention but the duration of that effect is varied. Five studies repeated the QoL measures at least six months after the intervention and only two found a sustained significant improvement [28, 30]. These both consisted of sessions which were spread out over time, which may be a better intervention strategy than one-off courses. Fraser et al. also delivered their intervention over a period of 8 weeks but were unable to demonstrate a significant effect at 6 month follow-up [35]. They suggested the addition of a booster course to the programme. It is likely that other factors may also influence the duration of improvement.
It was difficult to identify mechanisms that make a group intervention for PWE effective. This is particularly true of co-interventions, where group effects cannot be separated out from additional support. Psychological interventions performed well on QoL and seizure frequency (Table 1) [36, 37, 32] although they had very small sample sizes (n = 17, 27 and 37). This suggests that including behavioural therapy in self-management interventions may be important to affect QoL.
Although some studies found positive trends for QoL improvements from baseline measurements, the scores were not necessarily statistically different between study groups. Many were pilot studies with small sample sizes and may not have had adequate power to detect important changes. One study that encountered this problem calculated a required sample size of 180 participants but recruitment difficulties resulted in a final sample of only 55 [31]. Larger-scale trials are needed to explore this further.
Another factor that may have contributed to the lack of significant effect is the use of unsuitable outcomes. Two studies found improvements only in measures developed specifically for the trial, despite including a variety of other outcomes [15, 34]. This suggests that the existing scales may not be optimal for evaluating effects of self-management interventions in this setting.
The diversity of outcome measures used across all studies made comparison difficult. There were five scales used to assess QoL, of which two were epilepsy-specific. Four studies did not use any QoL questionnaires although their chosen outcomes (e.g. seizure frequency) can be assumed to affect QoL. This highlights lack of consensus on the most appropriate measures for complex interventions in epilepsy.
Only one study used semi-qualitative data in their evaluation, collecting written comments from participants in an open-ended satisfaction survey [35]. They received positive comments about the intervention with 47% of respondents mentioning the value of meeting other PWE. However, response rates were uncertain and there were no interviews to explore participants’ views. Guidelines from the Medical Research Council recommend the inclusion of qualitative methods as part of a process evaluation for complex interventions [45]. In light of this, it would be useful to collect further qualitative data on how and why group self-management interventions are beneficial.
The diversity of study settings also complicates interpretation. As trials were conducted across 13 countries with wide-ranging cultural and socioeconomic backgrounds, baseline standards of care and health literacy were likely different. Furthermore, participants in each setting may not be representative of the wider population. This was particularly relevant in the Seattle-based study which typically recruited highly educated participants, some of whom were volunteers, limiting the generalisability of their findings to other western countries in which health care is provided to all socio-economic groups [35].
There are several limitations associated with the present review. We were unable to perform a meta-analysis due to significant heterogeneity of outcome measures observed across the studies. Moreover, not all Cochrane review tools were utilised when evaluating the quality of studies included. Findings from the review may also be limited due to biases arising from initial search criteria (i.e., article language and publication date).

Suggestions for future research

Based on the evidence available to date, it seems that QoL is rarely affected long term by educational interventions. Thus to have a better chance of affecting QoL, self-management interventions should include psychological components. If group self-management education is to be offered as part of standard outpatient care for PWE, as DESMOND is for people with diabetes, then future research should examine the feasibility and cost-effectiveness of implementation. Although this review did not specifically search for published articles with health economics data, we found no discussion of the cost of implementing self-management education courses for PWE in the community. This would be valuable in the context of similar programmes being implemented in countries with public healthcare systems.

Conclusions

The studies evaluating group self-management interventions for PWE found encouraging results. There is some evidence that psychoeducational measures can be delivered to improve self-management, seizure control, and QoL in adults with poorly-controlled epilepsy. The MOSES programme has been offered in German-speaking countries for over a decade and other countries are investigating similar interventions [15]. Promising findings, along with demand from patients for more information about epilepsy, are indications for continued interest in group self-management interventions for PWE.
This review illustrates the need for clarity regarding outcome measures in this field of epilepsy research. Additionally, large-scale trials of group self-management interventions, combining quantitative, qualitative, and cost-effectiveness data, are required in the future.

Acknowledgements

The authors would like to acknowledge our clinical trial administrator, Carly Pearson.

Funding

This research was in part funded by the National Institute for Health Research (NIHR), under the Health Technology Assessment Programme (09/165/01), including salaries for AM and GW. There are no further funding sources to declare. The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, NIHR, MRC, CCF, NETSCC, HTA programme, or Department of Health.

Availability of data and materials

Not applicable as no datasets were generated.

Authors’ contributions

AS was responsible for writing the first major draft of the manuscript, evaluating each article included with the review, and carrying out subsequent revisions of the manuscript. AM evaluated each of the articles included with the review and carried out moderate revisions of the manuscript in preparation for publication. GW evaluated each paper included with the review, contributed to the development of the manuscript and provided feedback throughout manuscript preparation. LR conceived of the study and its design and methods, and provided supervision and feedback throughout. All authors read and approved the final manuscript.

Competing interests

There are no further competing interests to declare.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Appendix 1

Search strategies

Medline (Ovid) search strategy

1.
exp. Epilepsy/
 
2.
epilep*
 
3.
seizures
 
4.
exp. Self Care/
 
5.
exp. Self Efficacy/
 
6.
exp. Patient Education as Topic/
 
7.
educational program
 
8.
self-management
 
9.
group intervention
 
10.
complex intervention
 
11.
1 or 2 or 3
 
12.
Limit 11 to (English language and yr. = “1995 - Current”)
 
13.
4 or 5 or 6 or 7 or 8 or 9 or 10
 
14.
Limit 13 to (English language and yr. = “1995 - Current”)
 
15.
12 and 14
 
16.
Limit 15 to (clinical trial or controlled clinical trial or pragmatic clinical trial or randomized controlled trial)
 

PsycINFO search strategy

1.
Exp Epilepsy/
 
2.
epilep*
 
3.
seizures
 
4.
1 or 2 or 3
 
5.
self-management
 
6.
exp. Self Efficacy/
 
7.
group intervention
 
8.
complex intervention
 
9.
patient education
 
10.
self care
 
11.
educational program*
 
12.
5 or 6 or 7 or 8 or 9 or 10 or 11
 
13.
12 and 4
 
14.
limit 13 to (English language and yr. = “1995-Current”)
 
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

BMC Neurology 1/2017 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Meistgelesene Bücher in der Neurologie & Psychiatrie

  • 2016 | Buch

    Neurologie

    Das Lehrbuch vermittelt Ihnen das gesamte Neurologie-Prüfungswissen für Ihr Medizinstudium und bereitet auch junge Assistenzärzte durch detailliertes Fachwissen optimal auf die Praxis vor. Die komplett überarbeitete Auflage enthält sechs neue, interdisziplinäre Kapitel.

    Herausgeber:
    Werner Hacke
  • 2016 | Buch

    Komplikationen in der Neurologie

    Das Buch schildert Ereignisse im Rahmen der Neuromedizin, die während der Diagnostik und Therapie neurologischer Erkrankungen und Symptome auftreten können. Die Fallbeispiele sensibilisieren Sie für mögliche Risikofaktoren, um das Auftreten solcher Komplikationen zu vermeiden.

    Herausgeber:
    Frank Block
  • 2017 | Buch

    Facharztwissen Psychiatrie, Psychosomatik und Psychotherapie

    Leitsymptome, Untersuchungsmethoden, Krankheitsbilder, Notfälle & Co. – mit der Neuauflage des "Facharztwissens" sind Sie auf die Facharztprüfung in Psychiatrie und Psychotherapie optimal vorbereitet. In dieser 2. Auflage sind die Kapitel zu psychosomatischen Störungen deutlich ausgebaut.

    Herausgeber:
    Prof. Dr. Dr. Frank Schneider
  • 2019 | Buch

    Kompendium der Psychotherapie

    Für Ärzte und Psychologen

    Dieses Werk wendet sich an Ärzte und Psychologen, die an psychiatrischen und psychosomatischen Kliniken oder an Psychotherapeutischen Ausbildungsinstituten arbeiten und in den vorhandenen Lehrbüchern der Psychotherapie den Brückenschlag zur …

    Herausgeber:
    Tilo Kircher